Moderna's Dual Vaccine Approved in Europe
April 24, 2026 at 21:11
0
✦ AI Summary
- Europe grants approval for Moderna's mRNA combo vaccine
- This is the first vaccine targeting both flu and COVID-19
- Moderna aims to improve immunization for high-risk adults
Moderna has received approval in Europe for its combination vaccine targeting both flu and COVID-19, while the U.S. has yet to authorize it. The European Commission greenlighted the mRNA-1083, also known as mCOMBRIAX, making it the first globally sanctioned dual vaccine for these respiratory viruses. This decision follows a favorable review from a crucial committee of the European Medicines Agency in February.
Moderna CEO Stéphane Bancel emphasized the vaccine's potential to streamline immunizations for adults, particularly those at higher risk, stating, "mCOMBRIAX offers an important new option for Europeans while enhancing the resilience of healthcare systems across Europe."
Share: